Overall Score

Revenue Model

Revenue remains minimal at $0.28/share TTM, while price-to-sales is 12.0x, indicating a very small commercial base relative to valuation.

No dividend support; dividend yield and payout ratio remain 0.

Profitability

Margins remain deeply negative, with gross margin at -3.2%, operating margin at -33.3%, and net margin at -33.8%.

Returns on capital are still severely negative, including ROIC at -171.9% and ROE at -160.3%.

Cash Flow Quality

Operating cash flow and free cash flow remain negative, with FCF yield at -248.5% and OCF yield at -263.9%.

Cash conversion remains poor, with a cash conversion cycle of 228.5 days and operating cash flow per share at -8.42.

Balance Sheet Strength

Liquidity is adequate, with a current ratio of 2.27 and quick ratio of 1.99.

Leverage is manageable for now, with debt-to-equity at 0.54 and net debt to EBITDA at 0.13.

Scalability

Operating leverage is not yet evident, as asset turnover is only 0.04x and fixed asset turnover is 0.11x.

Heavy R&D and SG&A spend relative to revenue, at 19.9% and 10.1% respectively, continues to pressure scalability.